scholarly journals Hypervirulent Klebsiella pneumoniae infection in a woman with a CDH1 gene mutation

IDCases ◽  
2021 ◽  
Vol 23 ◽  
pp. e01000
Author(s):  
Alexander J. Kaye ◽  
Adam T. Chin ◽  
Michelle C. Liang ◽  
Roberto Viau Colindres
2012 ◽  
Vol 107 ◽  
pp. S296
Author(s):  
Rebecca Rawl ◽  
Heather Brooks ◽  
Martin Scobey ◽  
Amit Aravapalli

2014 ◽  
Vol 2014 ◽  
pp. 1-4 ◽  
Author(s):  
Preethi Sekar ◽  
Jyotsna Naresh Bharti ◽  
Jitendra Singh Nigam ◽  
Ankit Sharma ◽  
Priyanka Bhatia Soni

Background. Study of tumor molecular characteristics is necessary to understand both the risk of breast cancer recurrence and the response to therapy.Aims. To evaluate p53, HoxD10, and E-cadherin status in breast cancer and to correlate with histological grade and other prognostic factors.Material and Methods. The study was conducted in 60 cases of invasive ductal carcinoma NOS with 20 cases belonging to each grade and evaluation of p53 was done by IHC and that of HoxD10 and E Cadherin status by PCR and correlation was done with histological grade and other prognostic factors.Result. p53 expression was seen in 71.67% (43/60) of the tumors. HoxD10 gene was downregulated in 46.67% (28/60) of the tumors. p53 overexpression and lower HoxD10 mRNA levels showed statistically significant association higher histological grade of the tumor (P<0.05). CDH1 gene mutation was seen in 60% (15/25) of the tumors. No significant association was found between p53 expression, HoxD10 gene, CDH1 gene mutation, and other prognostic factors.Conclusion. p53 over expression and lower HoxD10 mRNA levels were found to be significantly associated with higher grade tumours. This suggests that p53 and HoxD10 gene play an important tumor suppressor role and the loss of which results in breast cancer progression.


2020 ◽  
Vol 14 (3) ◽  
pp. 270-289
Author(s):  
Massoumeh Chanbari ◽  
Reza Mirnejad ◽  
Ebrahim Babapour ◽  
◽  
◽  
...  

2020 ◽  
Vol 216 (5) ◽  
pp. 152912
Author(s):  
Alan Aitchison ◽  
Christopher Hakkaart ◽  
Martin Whitehead ◽  
Sadaf Khan ◽  
Sabeehuddin Siddique ◽  
...  

2018 ◽  
Vol 17 (4) ◽  
pp. 48-52
Author(s):  
L. N. Lyubchenko ◽  
M. G. Filippova ◽  
O. A. Anurova ◽  
P. B. Nazliev ◽  
I. S. Stilidi

For patients with an identified germline E-cadherin-1 (CDH1) mutation, prophylactic gastrectomy is the treatment of choice to eliminate the high risk of developing diffuse gastric  cancer. The case report describes a rare case of hereditary diffuse gastric cancer (HDGC)  associated with CDH1 gene mutation, which is reported in the Russian population for the first  time. In 2013, a 28-year- old woman was referred to Clinical Oncogenetics Laboratory with a  family history of gastric cancer. Molecular genetic analysis revealed CDH1 gene mutation. The  lifetime risk of cancer in mutation positive members is more than 80. Histological examination  of gastric biopsy specimens obtained during endoscopy revealed isolated signet ring cells in the  lamina propria. Spleenpreserving D2-lymphodissection and total gastrectomy with Roux-en-Y  reconstruction with a jejunal reservoir formation were performed at the Abdominal Oncology Surgery Department.


Sign in / Sign up

Export Citation Format

Share Document